Search Within

Genitourinary Oncology Service

  1. "Aseem Anand"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (18)
Groups
  1. Department of Medicine (51)
  2. Solid Tumor Oncology Division (51)
  3. Epidemiology and Biostatistics (20)
  4. GSK Faculty (20)
  5. Biostatistics Service (19)
  6. Human Oncology and Pathogenesis Program (12)

More Groups

People
  1. Aseem Anand (51)
  2. Howard Scher (45)
  3. Daniel Danila (33)
  4. Martin Fleisher (33)
  5. Glenn Heller (18)
  6. Michael Morris (14)

More People

Years
  1. 2022 (2)
  2. 2019 (1)
  3. 2017 (2)
  4. 2016 (4)
  5. 2015 (2)
  6. 2014 (3)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Clinical Cancer Research (3)
  3. European Urology (2)
  4. Journal of Molecular Diagnostics (2)
  5. Journal of Nuclear Medicine (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. Elsevier Science, Inc. (6)
  3. American Association for Cancer Research (5)
  4. Springer (3)
  5. Society of Nuclear Medicine (2)
  6. Wiley Blackwell (2)

More Publishers

Results (51)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Automated bone scan index to optimize prostate cancer working group radiographic progression criteria for men with metastatic castration-resistant prostate cancer
    Journal Article

    Anand, A.; Heller, G.; Fox, J.; Danila, D. C.; Bjartell, A.; Edenbrandt, L.; Larson, S. M.; Scher, H. I.; Morris, M. J.
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Analytical performance of aPROMISE: Automated anatomic contextualization, detection, and quantification of [(18)F]DCFPyL (PSMA) imaging for standardized reporting
    Journal Article

    Johnsson, K.; Brynolfsson, J.; Sahlstedt, H.; Nickols, N. G.; Rettig, M.; Probst, S.; Morris, M. J.; Bjartell, A.; Eiber, M.; Anand, A.
    European Journal of Nuclear Medicine and Molecular Imaging (2022)

    Fulltext@MSK | Save
  • High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
    Journal Article

    Razavi, P.; Li, B. T.; Brown, D. N.; Jung, B.; Hubbell, E.; Shen, R.; Abida, W.; Juluru, K.; De Bruijn, I.; Hou, C.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Phase 3 prognostic analysis of the automated bone scan index (aBSI) in men with bone-metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Armstrong, A. J.; Edenbrandt, L.; Bondesson, E.; Anand, A.; Nordle, O.; Carducci, M. A.; Morris, M. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Translating prostate cancer working group (PCWG) criteria into a quantitative progression biomarker in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Anand, A.; Heller, G.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical validity of detecting circulating tumor cells by AdnaTest assay compared with direct detection of tumor mRNA in stabilized whole blood, as a biomarker predicting overall survival for metastatic castration-resistant prostate cancer patients
    Journal Article

    Danila, D. C.; Samoila, A.; Patel, C.; Schreiber, N.; Herkal, A.; Anand, A.; Bastos, D.; Heller, G.; Fleisher, M.; Scher, H. I.
    The Cancer Journal (2016)

    Fulltext@MSK | Save
  • Automated bone scan index as a quantitative imaging biomarker indicative of efficacy to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC)
    Meeting Abstract

    Anand, A.; Morris, M. J.; Larson, S. M.; Ohlsson, M.; Joseffson, A.; Helgstrand, J. T.; Edenbrandt, L.; Oturai, P. S.; Roeder, M. A.; Bjartell, A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
    Journal Article

    Anand, A.; Morris, M. J.; Larson, S. M.; Minarik, D.; Josefsson, A.; Helgstrand, J. T.; Oturai, P. S.; Edenbrandt, L.; Røder, M. A.; Bjartell, A.
    EJNMMI Research (2016)

    Fulltext@MSK | Save
  • Analytic validation of the automated bone scan index as an imaging biomarker to standardize quantitative changes in bone scans of patients with metastatic prostate cancer
    Journal Article

    Anand, A.; Morris, M. J.; Kaboteh, R.; Bath, L.; Sadik, M.; Gjertsson, P.; Lomsky, M.; Edenbrandt, L.; Minarik, D.; Bjartell, A.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications
    Journal Article

    Rathkopf, D. E.; Larson, S. M.; Anand, A.; Morris, M. J.; Slovin, S. F.; Shaffer, D. R.; Heller, G.; Carver, B.; Rosen, N.; Scher, H. I.
    Cancer (2015)

    Fulltext@MSK | Save